Metastatic heterogeneity in a spontaneously metastatic HSV-2 induced hamster fibrosarcoma: association of phenotypic and genotypic properties with metastatic potential
- PMID: 3036738
Metastatic heterogeneity in a spontaneously metastatic HSV-2 induced hamster fibrosarcoma: association of phenotypic and genotypic properties with metastatic potential
Abstract
A spontaneously metastatic tumour of hamsters and cell lines derived from its in vivo metastatic deposits, or from in vitro cloning were compared for immunobiological and genotypic variation and correlation sought with regard to metastatic potential. Cell lines were established from seven individual lung metastases following primary tumour resection of the parent (HSV-2-333-2-26) cell line. When inoculated subcutaneously, and upon resection of the subsequent tumour mass, four cell lines (MetA, MetB, MetE and MetF) demonstrated greater, one similar (MetG) and two (MetC and MetD) less metastatic capacity compared with the parent tumour line. In further studies cell lines were established in vitro by single cell cloning of the parent tumour either by limiting dilution or soft agar cloning. In vivo tumour resection experiments showed eight cell lines (S4, S7, S4A, S7A, S7B, C1.1, C1.4 and C1.5) to have an increased metastatic potential and five cell lines (S8, S9, S8B, S9D and S9E) a decreased metastatic potential compared to the parental line. Karyotypic analysis of the cells revealed that all highly metastatic cell lines were of a near diploid genotype, whilst non- and weakly metastatic cell lines, including the parental line, were aneuploid or near tetraploid. The immunobiological characteristics of these cell lines was studied. Assessment of in vivo immunogenicity showed that eight clones (MetA, MetB, MetE, MetF, S7A, C1.1, C1.4 and C1.5) were non-immunogenic whilst the parental tumour line and three clones (MetC, MetD and MetG) exhibited a strong transplantation rejection antigen; immunogenicity showed an inverse correlation with metastatic potential. Susceptibility to NK cytolysis was demonstrated for cell lines exhibiting a weak or non-metastatic/immunogenic phenotype. The origin of metastatic variants and their association with genotype and immunobiological properties is discussed.
Similar articles
-
Rapid phenotype variation in cells derived from lung metastases of KHT fibrosarcoma.Invasion Metastasis. 1984;4(4):225-37. Invasion Metastasis. 1984. PMID: 6533094
-
Karyotypic and phenotypic variations between cell lines established from a primary colorectal tumour and two corresponding metastases from one patient.Invasion Metastasis. 1993;13(5):253-66. Invasion Metastasis. 1993. PMID: 7960578
-
DNA content of murine fibrosarcoma cell lines with varying metastatic potential.Cancer Res. 1985 Nov;45(11 Pt 2):5757-61. Cancer Res. 1985. PMID: 4053048
-
[The rate of in vivo selection of highly metastatic and resistance-inhibiting variants of tumor cells].Biull Eksp Biol Med. 1986 May;101(5):607-10. Biull Eksp Biol Med. 1986. PMID: 3708148 Russian.
-
Lipid characteristics in metastatic cells.Clin Exp Metastasis. 1999 Jun;17(4):271-6. doi: 10.1023/a:1006662811948. Clin Exp Metastasis. 1999. PMID: 10545012 Review.
Cited by
-
Chemokines induce the cellular migration of MCF-7 human breast carcinoma cells: subpopulations of tumour cells display positive and negative chemotaxis and differential in vivo growth potentials.Clin Exp Metastasis. 1999 Jul;17(5):389-96. doi: 10.1023/a:1006657109866. Clin Exp Metastasis. 1999. PMID: 10651305
-
A positive association between agonist-induced cyclic AMP production in vitro and metastatic potential in murine B16 melanoma and hamster fibrosarcoma.Clin Exp Metastasis. 1990 Sep-Oct;8(5):461-74. doi: 10.1007/BF00058156. Clin Exp Metastasis. 1990. PMID: 2167781
-
Modulation of type IV collagenase and plasminogen activator in a hamster fibrosarcoma by basement membrane components and lung fibroblasts.Br J Cancer. 1988 May;57(5):475-80. doi: 10.1038/bjc.1988.110. Br J Cancer. 1988. PMID: 2840108 Free PMC article.
-
Comparison of excision versus cryosurgery of an HSV-2-induced fibrosarcoma. I. Survival, extent of metastatic disease and host immunocompetence following surgery.Cancer Immunol Immunother. 1988;26(2):161-8. doi: 10.1007/BF00205610. Cancer Immunol Immunother. 1988. PMID: 2834055 Free PMC article.
-
Characterisation of suppressor cells generated following cryosurgery of an HSV-2-induced fibrosarcoma.Cancer Immunol Immunother. 1988;26(2):169-75. doi: 10.1007/BF00205611. Cancer Immunol Immunother. 1988. PMID: 2834056 Free PMC article.